BioSig Technologies, Inc. announced that on August 13, 2025, it entered into an Underwriting Agreement to sell 3,852,149 shares of common stock at $3.90 per share, aiming to raise approximately $15.02 million. The offering closed on August 15, 2025, and funds are intended for gold purchases and working capital.